A clinical trial for Heart Disease Risk assessment and treatment of patients with high risk.

Assessment of Cardiovascular Disease (CVD) Risk and Ayurvedic Preventive Intervention in High Risk Individuals

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018723

Enrollment

Registered

2019-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I00-I99- Diseases of the circulatory system

Interventions

Intervention1: Capsulated Ayurvedic Formulation containing 3 different herbal extract: A poly herbal compound in Capsule form containing 500 mg extract of Guggul (Commiphora mukul), Pushkarmool (Innul

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Hyperlipidemia and having more than 10 % of CVD Risk will be included.

Exclusion criteria

Exclusion criteria: ï?¶ Patients with Hypertension ï?¶ Patients with Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Improvements in parameters of Lipid profileTimepoint: 90 days	—

Secondary

Measure	Time frame
Reduction in CVD Risk ScoreTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Saurabha Nayak

Gopabandhu Ayurveda Mahavidyalaya, Puri, Odisha

bbkhuntia69@gmail.com9437499423

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026